Official Journal of Faculty of Medicine, Universiti Teknologi MARA

     

    LEFT: The picture was painted after a diagnosis of inoperable cancer was revealed to the painter. RIGHT: This was when the same painter readmitted for pathological fracture after a course of palliative TKI.

     PREVIOUS ISSUE

      JUNE 2018
       VOLUME 3 ISSUE 1
       https://doi.org/10.24191/jchs.v3i1
       VOLUME 3 ISSUE 1 (S)
       https://doi.org/10.24191/jchs.v3i1(S)

    Editorial

    1. Competency-Based Medical Education, Here Next?
      Mohamad Fauzi Abdul Rani, Sabariah Abdul Rahman ; p1-4
      https://doi.org/10.24191/jchs.v3i1.6149
      PDF

    Clinical Quiz

    1. JCHS-CQ-01-2018
      Liyana Dhamirah Aminuddin, Tarita Taib, Meera Kuppusamy
      https://doi.org/10.24191/jchs.v3i1.6159

      PDF(Question)
      PDF(Answer)

    Click Here to Download PDF Version

    Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 1 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 2 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 3 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 4 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 5 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 6 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 7 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 8 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 9 Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia 10

    Copyright © 2016 Faculty of Medicine, University Teknologi MARA. All Rights Reserved.